Internal Medicine, Hematology & Oncology · Henderson, NV
NPI
1699772210
Since 2005
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
3175 Saint Rose Pkwy Fl 2
Henderson, NV, 89052
Phone (702) 724-8787
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.8M
77,903 services
Medicare patients, 2024
412
Average age 73
Drug cost, 2024
$8.1M
3,113 prescriptions
Company payments, 2025
$45K
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Russell P Gollard was code J9271 (injection, pembrolizumab, 1 mg), 4,400 times for 11 patients. In total Russell P Gollard billed 77,903 services in 121 codes, and Medicare paid $1.8M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-05-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J9271 Injection, pembrolizumab, 1 mg | Office | 4,400 | 11 | $44.65 | $196K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 2,820 | 38 | $0.09 | $252 |
| 99214 Office E&M - Established | Office | 1,007 | 281 | $88.06 | $89K |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 370 | 11 | $0.74 | $274 |
| 85025 Blood Count | Office | 267 | 63 | $7.61 | $2,032 |
| 96367 Intravenous Infusion, Hydration | Office | 237 | 39 | $21.90 | $5,190 |
| 96413 Chemotherapy Administration | Office | 150 | 43 | $97.45 | $15K |
| 96372 Injection Administration | Office | 129 | 34 | $10.57 | $1,364 |
| 96401 Chemotherapy Administration | Office | 107 | 13 | $55.15 | $5,901 |
| 96365 Intravenous Infusion, Hydration | Office | 99 | 26 | $48.03 | $4,755 |
| 96523 Chemotherapy | Office | 89 | 35 | $17.84 | $1,588 |
| J1200 Injection, diphenhydramine hcl, up to 50 mg | Office | 68 | 19 | $0.64 | $43.83 |
| J3490 Unclassified drugs | Office | 58 | 11 | $0.32 | $18.29 |
| 96375 Injection Administration | Office | 51 | 11 | $11.87 | $605 |
| 99195 Treatment - Miscellaneous | Office | 47 | 21 | $66.48 | $3,125 |
By year: 2022 $2.3M for 161,666 services; 2023 $2.1M for 135,105 services; 2024 $1.8M for 77,903 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 267 | 63 | $7.61 | $2,032 |
| 80047 Clinical Chemistry | 32 | 16 | $13.46 | $431 |
Medicare prescription drug claims, 2024
In 2024, the drug Russell P Gollard prescribed most often to Medicare patients was Letrozole, with 310 prescriptions and refills. In total Russell P Gollard wrote 3,113 Medicare prescriptions that cost $8.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Letrozole Generic | 310 | 700 | 87 | $6,036 |
| Eliquis Apixaban | 175 | 232 | 37 | $136K |
| Ondansetron Hcl Generic | 132 | 143 | 71 | $1,573 |
| Anastrozole Generic | 119 | 282 | 38 | $1,028 |
| Abiraterone Acetate Generic | 78 | 78 | 11 | $63K |
| Temazepam Generic | 71 | 77 | 22 | $717 |
| Potassium Chloride Generic | 70 | 104 | 22 | $648 |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 69 | 77 | 56 | $1,773 |
| Revlimid Lenalidomide | 69 | 69 | 15 | $1.3M |
| Oxycodone Hcl Generic | 68 | 68 | 17 | $2,767 |
| Prednisone Generic | 61 | 80 | 28 | $233 |
| Alprazolam Generic | 59 | 64 | 18 | $543 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 59 | 59 | 24 | $2,202 |
| Gabapentin Generic | 58 | 78 | 17 | $568 |
| Folic Acid Generic | 53 | 91 | 18 | $299 |
Brand drugs: - claims; generic drugs: 2,397 claims; opioid claims: 253.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Russell P Gollard $45K ($45K in general payments such as food, travel and fees) from 18 companies. The largest payer was Sobi, Inc with $26K.
| Company | Payments | Amount |
|---|---|---|
| Sobi, Inc SOBI.ST | 19 | $26K |
| EMD Serono, Inc. MRK.DE | 7 | $7,721 |
| Syndax Pharmaceuticals, Inc. SNDX | 10 | $4,774 |
| SpringWorks Therapeutics, Inc. | 2 | $2,514 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $2,078 |
| Deciphera Pharmaceuticals Inc. | 2 | $774 |
| Pfizer Inc. PFE | 2 | $376 |
| Janssen Scientific Affairs, LLC JNJ | 2 | $176 |
| Caris MPI, Inc. | 2 | $128 |
| Regeneron Healthcare Solutions, Inc. REGN | 5 | $102 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.